Texas Halo Fund

Texas Halo Fund is a venture capital firm based in Houston, Texas, established in 2012. The firm focuses on investing in early-stage businesses with strong growth potential and capable management teams. Texas Halo Fund seeks to identify compelling investment opportunities across various industries and geographic locations, prioritizing those that exhibit promising prospects. Its investment strategy includes a preference for sectors such as healthcare and information technology, while also considering businesses in the software sector. The firm aims to generate high returns for its investors while minimizing risk, typically investing with a horizon of five to seven years.

Kyra Doolan

Managing Director, Funds II, III and IV

Kevin King

Managing Director, Funds II, III and IV

Christy Luquire

Managing Director

Christina Luquire

Managing Director and Fund I Deal Committee Member

David Steakley

Managing Director and Funds I, II, III and IV

Rob Tucci

Managing Director

Bill Wheelock

Managing Director

93 past transactions

Drusolv Therapeutics

Convertible Note in 2022
Drusolv Therapeutics is a clinical-stage drug company developing a novel, high-dose statin for early intervention in age-related macular degeneration. Their product ocustatin is aimed at patients who are still in the intermediate stage of the disease and currently have very limited options to prevent progression to late-stage vision loss. Ocustatin was developed at Harvard University and has been validated in a very successful proof-of-concept clinical trial that showed a 75% reduction in progression to late-stage blindness. John Edwards, the founder and CEO of Drusolv, is a serial entrepreneur with extensive experience in AMD.

Rellevate

Seed Round in 2022
Rellevate, LLC is a financial services company based in Stamford, Connecticut, established in 2019. It specializes in providing digital banking services aimed at enhancing consumer financial empowerment. Rellevate's offerings include digital accounts that earn interest, along with features such as Pay Any-Day, bill payment, and money transfer services. These products are primarily offered through employers, aiming to improve employee retention and satisfaction. By enabling users to manage their finances more effectively, Rellevate facilitates greater access to and control over their money, allowing them to make payments anytime and anywhere.

Dynamic Light

Convertible Note in 2022
Dynamic Light, established in May 2018 and based in Austin, Texas, specializes in advanced blood flow imaging technology aimed at enhancing patient care and reducing healthcare costs. The company’s innovative solution enables real-time, continuous, and quantitative visualization of blood flow in living tissues, allowing surgeons to make informed decisions during procedures. By providing high-resolution imaging without the need for dyes or procedural interruptions, Dynamic Light's technology supports improved surgical outcomes and patient management.

Sonnest

Convertible Note in 2022
Developer of an electrically sensitive imaging agent designed to assess and monitor the perfusion, structure, and function of the heart. The company's voltage-activated imaging agent is electrically sensitive and activates with ultrasound and the heart's local electric field if the heart tissue is perfused and viable, enabling clinicians to improve patient care and outcomes.

Global Neighbor

Seed Round in 2021
We seek to accelerate adoption of sustainable ag practices and maximize farm profits through non-chemical, directed energy (DE) solutions. We currently have consumer use DE weed control products selling online and in big-box retailers. Our next product, the WDSD, addresses the challenge of herbicide-resistant weeds in grain crops. The WDSD quickly attaches to combine harvesters and applies DE to weed seeds making them nonviable without chemicals.

Vartega

Seed Round in 2021
Vartega is a technology development company focused on recycling carbon fiber reinforced plastics, specifically through its innovative patent-pending processes. Established in 2014 and located in Golden, Colorado, Vartega aims to provide low-cost carbon fiber for various mass market applications across several industries, including aerospace, automotive, wind energy, and sporting goods. The company produces recycled carbon fiber suitable for use in nonwoven fabrics, thermoplastic pellets, yarns, and 3D printing filaments. By developing alternative recycling technologies and equipment, Vartega seeks to contribute to the sustainability of carbon fiber materials and enhance their accessibility for broader applications.

Vartega

Series A in 2021
Vartega is a technology development company focused on recycling carbon fiber reinforced plastics, specifically through its innovative patent-pending processes. Established in 2014 and located in Golden, Colorado, Vartega aims to provide low-cost carbon fiber for various mass market applications across several industries, including aerospace, automotive, wind energy, and sporting goods. The company produces recycled carbon fiber suitable for use in nonwoven fabrics, thermoplastic pellets, yarns, and 3D printing filaments. By developing alternative recycling technologies and equipment, Vartega seeks to contribute to the sustainability of carbon fiber materials and enhance their accessibility for broader applications.

Resonant Therapeutics

Series A in 2021
Resonant Therapeutics, Inc. is a biotechnology company based in Houston, Texas, founded in 2014. The company operates a proprietary discovery platform known as the Integrated Microenvironment Pathway Catalog and Triage (IMPaCT), which facilitates the rapid and simultaneous identification of novel therapeutic targets and high-affinity, functional antibodies. By leveraging insights into the tumor microenvironment and the immune system, Resonant Therapeutics' platform can analyze patient-derived tumor tissues or cell lines, including cancer stem cells, to uncover potential therapeutic candidates. The company's research initially focuses on breast and ovarian cancers, developing antibodies that demonstrate potent anti-tumor activity. These antibodies are designed to function effectively as standalone treatments or in combination with newer immunotherapies. Resonant Therapeutics has established a strategic alliance with Retrogenix Ltd. to enhance its drug discovery capabilities.

Rx Bandz

Convertible Note in 2021
Manufacturer of an auto-injector intended to deliver a wide range of injectable medications including viscous biologics and vaccines. The company's auto-injector provides a highly reliable and waterproof option to address the challenges patients, medics, and first responders face carrying emergency self-injectable medication and the company's pipeline includes device and formulation development for anaphylaxis, pain, non-compressible hemorrhage, overdose, and anti-chemical warfare, enabling patients to carry emergency self-injectable medication.

ReturnSafe

Seed Round in 2021
ReturnSafe Inc. is a BioSecurity company based in Austin, Texas, established in 2020. It specializes in providing solutions aimed at enhancing workplace safety by offering services such as screening, contact tracing, testing management, and vaccine status management. ReturnSafe's offerings include daily symptom screening, contact tracing methods, and vaccine management integrations. The company caters to various sectors, including general business, higher education, long-term care, manufacturing, and travel and hospitality. Founded by Tarun Nimmagadda and Jason Story, ReturnSafe aims to help organizations prevent viral outbreaks, particularly in the context of Covid-19, thereby ensuring a safer environment for employees and visitors.

Kegg

Seed Round in 2021
Kegg is a health technology company based in San Francisco, California, founded in 2017. It specializes in developing a two-in-one device that combines fertility tracking with pelvic floor exercises. Kegg's primary product is an innovative fertility tracker that enhances the chances of natural conception by accurately detecting the fertile window and ovulation up to seven days in advance. The device achieves this by analyzing changes in cervical fluid, providing essential data that was previously difficult to obtain. This information empowers women to make informed decisions regarding their reproductive health, thereby improving diagnosis, monitoring, and treatment options.

Work & Mother

Convertible Note in 2021
Work & Mother is a provider of lactation room services designed to support working mothers in achieving a better work-life balance. The company offers a network of fully equipped lactation suites located in commercial office buildings, providing essential amenities such as hospital-grade pumping equipment, refrigeration, and cleaning facilities. This setup allows employers to meet legal requirements for providing mothers' rooms, while also enhancing workplace wellness initiatives. Additionally, Work & Mother features a support app that offers resources to assist mothers in their breastfeeding journeys, ensuring they can maintain their breastfeeding goals with privacy and safety after returning to work. This comprehensive approach addresses the needs of working mothers, contributing to their well-being and that of their children.

Ictero Medical

Convertible Note in 2021
Ictero Medical is a medical devices company focused on developing innovative solutions for patients with gallstone disease. The company has created a minimally invasive gallbladder ablation tool that allows for the treatment of high-risk patients without the need for surgical removal of the gallbladder. This device can be utilized in interventional radiology suites and requires only minimal local anesthesia, thereby reducing the associated risks of traditional surgery. By offering a definitive treatment option, Ictero Medical aims to improve patient outcomes while minimizing complications related to gallbladder surgery.

Path Ex

Convertible Note in 2021
Path Ex, Inc. is a Nashville-based company that specializes in manufacturing extracorporeal blood cleansing equipment. Established in 2017, Path Ex has developed a proprietary technology designed to selectively separate and capture bacteria and toxins from human blood, specifically for the treatment of sepsis, a critical condition often resulting from blood-borne infections. This innovative approach focuses on removing intact bacteria from the bloodstream instead of relying on broad-spectrum antibiotics, making it effective against various bacteria types and drug-resistant strains. The technology aims to improve patient outcomes by reducing diagnostic times, lowering treatment costs, decreasing readmission rates, and ultimately decreasing sepsis-related fatalities.

Galen Data

Series A in 2021
Galen Data, Inc., founded in 2016 and based in Houston, Texas, offers a cloud-based software platform designed for the healthcare sector, specifically targeting medical device connectivity and data management. This turn-key solution allows medical device companies to centralize their data, ensuring secure storage and facilitating data visualization and analysis. The platform is designed to meet the needs of a wide range of clients, from startups to large medical technology and pharmaceutical companies, enabling them to focus on their core innovations without the burden of software design and data management complexities. Galen Data's system is compliant with FDA and CE Mark regulations, as well as HIPAA and GDPR requirements, and holds ISO 13485:2016 certification. By integrating with major electronic health record systems, the platform enhances patient compliance tracking and reduces regulatory risks, ultimately supporting healthcare providers in optimizing information usage for improved clinical outcomes.

Machfu

Series A in 2021
Machfu Inc. is a company that specializes in applications and infrastructure for the industrial Internet of Things (IoT), facilitating data, analytics, and visualization for industrial enterprises. Based in Rockville, Maryland, Machfu has developed a smartphone for machines that enhances communication between industrial assets and integrates them with both legacy systems and cloud-based platforms. The company's Mach-IT solution enables seamless communication among various pieces of equipment and information processing systems. Founded in 2015, Machfu aims to simplify the management of industrial IoT environments, providing real-time visibility into operations and equipping operators with the data needed to make informed decisions. This focus on ease of use allows companies to effectively manage their IIoT ecosystems, encompassing hardware, networking, and security.

Materna Medical

Series A in 2021
Materna Medical, Inc. is a medical device company based in Mountain View, California, specializing in products aimed at enhancing women's pelvic health and reducing childbirth-related injuries. Established in 2010, the company launched Milli in 2018, the first expanding vaginal dilator designed to alleviate pelvic pain, a condition affecting over 20 million women. Materna Medical is also conducting a clinical trial for Materna Prep, a device intended to be used during the first stage of labor to expedite delivery and minimize internal damage to the pelvic region. The innovative features of Materna's devices not only provide significant health benefits to patients but also aim to save physicians' time, shorten delivery durations, and reduce overall healthcare costs by decreasing the incidence of pelvic injuries.

Work & Mother

Pre Seed Round in 2021
Work & Mother is a provider of lactation room services designed to support working mothers in achieving a better work-life balance. The company offers a network of fully equipped lactation suites located in commercial office buildings, providing essential amenities such as hospital-grade pumping equipment, refrigeration, and cleaning facilities. This setup allows employers to meet legal requirements for providing mothers' rooms, while also enhancing workplace wellness initiatives. Additionally, Work & Mother features a support app that offers resources to assist mothers in their breastfeeding journeys, ensuring they can maintain their breastfeeding goals with privacy and safety after returning to work. This comprehensive approach addresses the needs of working mothers, contributing to their well-being and that of their children.

Sonnest

Series A in 2021
Developer of an electrically sensitive imaging agent designed to assess and monitor the perfusion, structure, and function of the heart. The company's voltage-activated imaging agent is electrically sensitive and activates with ultrasound and the heart's local electric field if the heart tissue is perfused and viable, enabling clinicians to improve patient care and outcomes.

Ikonopedia

Series D in 2021
Ikonopedia, LLC specializes in creating a cloud-based breast study interpretation and reporting system tailored for radiologists. The company offers a Mammography Reporting System that includes screening and diagnostic modalities, generating structured reports compliant with the Mammography Quality Standards Act. Additionally, it provides SonoPro, a web application designed to assist radiologists in interpreting diagnostic breast ultrasound exams. Ikonopedia's solutions enhance workflow efficiency and are utilized in telemammography and satellite clinics. The system features automated patient tracking, ensuring compliance with the ACR BI-RADS® Atlas 5th Edition and monitoring patients through all stages of the exam process. By providing clear and consistent clinical reports, Ikonopedia aims to improve patient safety and streamline operations for radiologists and their staff. Founded in 2012 and headquartered in Dallas, Texas, Ikonopedia addresses critical needs in breast radiology, ultimately contributing to better health outcomes for women.

CellChorus

Convertible Note in 2021
CellChorus provides comprehensive, dynamic analysis of single cells for biopharmaceutical companies. The company’s TIMING™ platform applies visual AI to evaluate cell activation, killing and movement as a function of time in order to maximize our understanding of the cellular function, state and phenotype of immuno-oncology and other therapies.

VenoStent

Seed Round in 2021
VenoStent, Inc. is a biomaterials and bioengineering company based in Nashville, Tennessee, with an additional office in Houston, Texas. Established in 2017, the company specializes in developing bioresorbable smart polymers aimed at enhancing vascular surgery outcomes. Its primary product, SelfWrap, is a perivascular wrap designed to minimize complications at the junctions of veins and arteries, particularly for dialysis patients. SelfWrap functions as an external stent that promotes outward vein growth and provides mechanical support, thereby reducing the risk of vein collapse. By focusing on innovative solutions in vascular care, VenoStent aims to improve patient outcomes and transform surgical practices.

Allotrope Medical

Series A in 2021
Allotrope Medical Inc. is a Houston-based medical device company focused on enhancing surgical procedures by developing innovative devices for ureter identification. The company's flagship product, the StimSite, is an intuitive handheld device that aids surgeons in quickly and accurately locating ureters during pelvic surgeries. This device features a simple design with a single button, eliminating the need for complex pre- and post-operative procedures. Founded in 2016, Allotrope Medical aims to improve surgical outcomes by providing tools that streamline the identification and localization of ureters, thus facilitating safer and more efficient operations.

Your Fare

Convertible Note in 2021
Your Fare is an online ordering management platform for restaurants that allows its users to track sales on one dashboard. It also allows restaurateurs to replace their online ordering tablets. It helps manage all 3rd party delivery services in a way that works best for its user. It was built for restaurant operators, by restaurant operators. It was founded in 2015 and is headquartered in Austin, Texas.

Chosen Diagnostics

Convertible Note in 2020
Chosen Diagnostics specializes in developing innovative biomarker diagnostic kits aimed at enhancing healthcare delivery for neonates. The company’s primary product is a test designed to diagnose a serious and potentially life-threatening bowel disease in preterm infants. This diagnostic kit provides more accurate results compared to existing methods, facilitating earlier medical intervention. By enabling timely detection of critical health issues, Chosen Diagnostics aims to improve treatment outcomes for thousands of low birth weight preterm infants, ultimately leading to better healthcare results in this vulnerable population.

Connectus Global

Seed Round in 2020
ConnectUs Global specializes in real-time location tracking and electronic permitting solutions aimed at enhancing geospatial intelligence across various environments, including buildings, airports, and manufacturing facilities. The company offers a dual frequency UWB solution, along with Wi-Fi-based badges, tags, and receivers that provide precise position data. This technology allows organizations to monitor assets and personnel effectively, improving production efficiency, streamlining inventory processes, and enhancing employee safety. By integrating sensors and detailed building information, ConnectUs Global enables clients to optimize their operational capabilities in diverse sectors.

ImmunoGenes

Series A in 2020
ImmunoGenes is a biotech company focused on the development of monoclonal antibodies using its proprietary platform technology that enhances immune responses through genetically-modified mice and rabbits overexpressing the neonatal Fc receptor. This patented IMG-AbS technology generates a higher quantity and diversity of B cell clones, facilitating robust immune responses to weakly immunogenic targets. As a result, ImmunoGenes produces high-quality monoclonal antibody candidates characterized by strong affinity and diversity, which pharmaceutical and biotech companies can leverage for the development of innovative therapeutics and diagnostics. The company collaborates with various partners, including pharmaceutical firms, academic institutions, and research organizations, to discover and develop antibody drugs aimed at challenging and novel targets, while also offering services such as custom antibody development and advisory support to enhance the efficiency of therapeutic target identification.

ImmunoGenesis

Venture Round in 2020
ImmunoGenesis develops science-driven immune therapies specifically designed to treat tumors lacking activated T cells or having other immune resistance mechanisms.

Kegg

Convertible Note in 2020
Kegg is a health technology company based in San Francisco, California, founded in 2017. It specializes in developing a two-in-one device that combines fertility tracking with pelvic floor exercises. Kegg's primary product is an innovative fertility tracker that enhances the chances of natural conception by accurately detecting the fertile window and ovulation up to seven days in advance. The device achieves this by analyzing changes in cervical fluid, providing essential data that was previously difficult to obtain. This information empowers women to make informed decisions regarding their reproductive health, thereby improving diagnosis, monitoring, and treatment options.

SIERA.AI

Series A in 2020
SIERA.AI specializes in providing software-as-a-service (SaaS) solutions for industrial vehicle inspections and offers Internet of Things (IoT) driver assistance technology aimed at enhancing safety and productivity. The company delivers a data-driven dashboard that allows enterprises to monitor individual drivers, thereby managing risk and improving operational efficiency. SIERA.AI's after-market middleware technology is compatible with various brands and models, enabling seamless integration with leading global manufacturers. Founded in 2017 and based in Austin, Texas, SIERA.AI is committed to advancing the capabilities of automated material handling through innovative technology.

TrueSpot

Seed Round in 2020
Developer of an Internet of Things asset location platform designed to manage automotive dealership inventory. The company's platform offers real-time location services and accelerates the speed of a costly, highly dispersed auto-reconditioning process, enabling dealers to find, track and map critical assets and processes.

Kegg

Seed Round in 2020
Kegg is a health technology company based in San Francisco, California, founded in 2017. It specializes in developing a two-in-one device that combines fertility tracking with pelvic floor exercises. Kegg's primary product is an innovative fertility tracker that enhances the chances of natural conception by accurately detecting the fertile window and ovulation up to seven days in advance. The device achieves this by analyzing changes in cervical fluid, providing essential data that was previously difficult to obtain. This information empowers women to make informed decisions regarding their reproductive health, thereby improving diagnosis, monitoring, and treatment options.

PyrAmes

Seed Round in 2020
PyrAmes is a healthcare technology company focused on transforming the delivery of medical care through advanced sensor measurement. The company has developed a paper-thin, flexible device that enables non-invasive, continuous blood pressure monitoring. This ultra-low power device is designed to be accurate and wireless, making it suitable for patients across all age groups, from newborns to seniors. By providing a pain-free method for blood pressure monitoring, PyrAmes aims to enhance the quality of care offered by healthcare providers, particularly for vulnerable populations such as neonates.

Nexus A.I.

Seed Round in 2020
Nexus A.I. is a software company founded in 2014 and headquartered in Chicago, Illinois. The company specializes in artificial intelligence applications designed for staffing and team building, catering to both external and internal needs. Its software assists organizations in identifying and curating employee skills and experiences to build effective teams, pinpoint skill gaps, enhance staffing efficiency, and align work with specific competencies. Additionally, the platform tracks skill progression and facilitates the organization of teams around project-based work, helping companies achieve optimal utilization rates. Nexus A.I. serves a global clientele, supporting users in over fifty countries across six continents.

Rellevate

Pre Seed Round in 2020
Rellevate, LLC is a financial services company based in Stamford, Connecticut, established in 2019. It specializes in providing digital banking services aimed at enhancing consumer financial empowerment. Rellevate's offerings include digital accounts that earn interest, along with features such as Pay Any-Day, bill payment, and money transfer services. These products are primarily offered through employers, aiming to improve employee retention and satisfaction. By enabling users to manage their finances more effectively, Rellevate facilitates greater access to and control over their money, allowing them to make payments anytime and anywhere.

Proov

Seed Round in 2020
Proov rapid response urine progesterone test strips empower women to know more about their cycles. Current in home, rapid response tests measure hormones in the first half of the menstrual cycle that are predictive of ovulation – LH, FSH, and Estrogen. But Proov tests enable a more complete picture by measuring progesterone, a hormone critical to conception and pregnancy and the ONLY hormone that allows women to confirm that ovulation has occurred. Don’t just predict ovulation. Proov it!

Allotrope Medical

Convertible Note in 2020
Allotrope Medical Inc. is a Houston-based medical device company focused on enhancing surgical procedures by developing innovative devices for ureter identification. The company's flagship product, the StimSite, is an intuitive handheld device that aids surgeons in quickly and accurately locating ureters during pelvic surgeries. This device features a simple design with a single button, eliminating the need for complex pre- and post-operative procedures. Founded in 2016, Allotrope Medical aims to improve surgical outcomes by providing tools that streamline the identification and localization of ureters, thus facilitating safer and more efficient operations.

Your Fare

Convertible Note in 2020
Your Fare is an online ordering management platform for restaurants that allows its users to track sales on one dashboard. It also allows restaurateurs to replace their online ordering tablets. It helps manage all 3rd party delivery services in a way that works best for its user. It was built for restaurant operators, by restaurant operators. It was founded in 2015 and is headquartered in Austin, Texas.

Renovion

Series A in 2020
Renovion, Inc. is a clinical-stage pharmaceutical company based in Chapel Hill, North Carolina, focused on developing innovative therapeutics for chronic inflammatory respiratory diseases. The company's primary product, Arina-1, is a nebulized therapy aimed at treating conditions such as cystic fibrosis, severe asthma, chronic obstructive pulmonary disorder (COPD), and bronchiectasis, particularly in patients who have undergone lung transplants. Founded in 2013, Renovion originated from research at the University of North Carolina-Chapel Hill, which identified a novel approach to reduce infection and manage airway inflammation. The company aims to address the mucus, inflammation, and infection challenges associated with various lung diseases through its advanced therapeutic solutions.

VenoStent

Seed Round in 2020
VenoStent, Inc. is a biomaterials and bioengineering company based in Nashville, Tennessee, with an additional office in Houston, Texas. Established in 2017, the company specializes in developing bioresorbable smart polymers aimed at enhancing vascular surgery outcomes. Its primary product, SelfWrap, is a perivascular wrap designed to minimize complications at the junctions of veins and arteries, particularly for dialysis patients. SelfWrap functions as an external stent that promotes outward vein growth and provides mechanical support, thereby reducing the risk of vein collapse. By focusing on innovative solutions in vascular care, VenoStent aims to improve patient outcomes and transform surgical practices.

Mi Padrino

Convertible Note in 2020
Mi Padrino is an online event planning service designed to assist families in organizing and funding celebrations rooted in Hispanic traditions, such as Quinceañeras, weddings, and baptisms. Founded by Kim Gamez, who has firsthand experience as a mother of five, the platform addresses the complexities involved in coordinating such significant events, enabling users to share event details with friends and family globally. Mi Padrino streamlines the planning process, making it easier for users to manage all aspects of their celebrations, regardless of the location of their loved ones. The service aims to simplify the organization of cherished cultural traditions, providing a unique solution tailored to the needs of the Hispanic community.

Path Ex

Convertible Note in 2020
Path Ex, Inc. is a Nashville-based company that specializes in manufacturing extracorporeal blood cleansing equipment. Established in 2017, Path Ex has developed a proprietary technology designed to selectively separate and capture bacteria and toxins from human blood, specifically for the treatment of sepsis, a critical condition often resulting from blood-borne infections. This innovative approach focuses on removing intact bacteria from the bloodstream instead of relying on broad-spectrum antibiotics, making it effective against various bacteria types and drug-resistant strains. The technology aims to improve patient outcomes by reducing diagnostic times, lowering treatment costs, decreasing readmission rates, and ultimately decreasing sepsis-related fatalities.

PyrAmes

Convertible Note in 2020
PyrAmes is a healthcare technology company focused on transforming the delivery of medical care through advanced sensor measurement. The company has developed a paper-thin, flexible device that enables non-invasive, continuous blood pressure monitoring. This ultra-low power device is designed to be accurate and wireless, making it suitable for patients across all age groups, from newborns to seniors. By providing a pain-free method for blood pressure monitoring, PyrAmes aims to enhance the quality of care offered by healthcare providers, particularly for vulnerable populations such as neonates.

Machfu

Series A in 2019
Machfu Inc. is a company that specializes in applications and infrastructure for the industrial Internet of Things (IoT), facilitating data, analytics, and visualization for industrial enterprises. Based in Rockville, Maryland, Machfu has developed a smartphone for machines that enhances communication between industrial assets and integrates them with both legacy systems and cloud-based platforms. The company's Mach-IT solution enables seamless communication among various pieces of equipment and information processing systems. Founded in 2015, Machfu aims to simplify the management of industrial IoT environments, providing real-time visibility into operations and equipping operators with the data needed to make informed decisions. This focus on ease of use allows companies to effectively manage their IIoT ecosystems, encompassing hardware, networking, and security.

Kegg

Convertible Note in 2019
Kegg is a health technology company based in San Francisco, California, founded in 2017. It specializes in developing a two-in-one device that combines fertility tracking with pelvic floor exercises. Kegg's primary product is an innovative fertility tracker that enhances the chances of natural conception by accurately detecting the fertile window and ovulation up to seven days in advance. The device achieves this by analyzing changes in cervical fluid, providing essential data that was previously difficult to obtain. This information empowers women to make informed decisions regarding their reproductive health, thereby improving diagnosis, monitoring, and treatment options.

Osperity

Series B in 2019
Osprey Informatics provides intelligent visual monitoring for industrial operations and transforms images and video into actionable enterprise intelligence. The company’s cloud-based platform, Osprey Reach, detects important operational events, analyzes related images and video along with data from other sensors and systems, and delivers visual reports and alerts to stakeholders across the enterprise. Industrial companies rely on Osprey Reach for enhanced operational efficiency, security, and safety and to remotely inspect facilities and equipment, monitor site activity, optimize labor productivity, and manage more assets without more people. Osprey Informatics was founded on 2012 and is headquartered in Calgary, Alberta, Canada.

Galen Data

Seed Round in 2019
Galen Data, Inc., founded in 2016 and based in Houston, Texas, offers a cloud-based software platform designed for the healthcare sector, specifically targeting medical device connectivity and data management. This turn-key solution allows medical device companies to centralize their data, ensuring secure storage and facilitating data visualization and analysis. The platform is designed to meet the needs of a wide range of clients, from startups to large medical technology and pharmaceutical companies, enabling them to focus on their core innovations without the burden of software design and data management complexities. Galen Data's system is compliant with FDA and CE Mark regulations, as well as HIPAA and GDPR requirements, and holds ISO 13485:2016 certification. By integrating with major electronic health record systems, the platform enhances patient compliance tracking and reduces regulatory risks, ultimately supporting healthcare providers in optimizing information usage for improved clinical outcomes.

Zibrio

Convertible Note in 2019
Zibrio is a balance diagnostics company based in Houston, Texas, founded in 2017. The company has developed a unique biometrics device that utilizes advanced knowledge of postural control and machine learning to detect subtle changes in balance. Originally based on technology developed for NASA to assess astronauts' stability post-spaceflight, Zibrio's technology aims to empower users to monitor and improve their health. The device provides insights into individual balance profiles, offering assistance and advice to enhance stability, reduce the risk of falls, and promote overall well-being. Through its innovative approach, Zibrio seeks to advance the understanding of balance and contribute to better health outcomes for its users.

Allotrope Medical

Convertible Note in 2019
Allotrope Medical Inc. is a Houston-based medical device company focused on enhancing surgical procedures by developing innovative devices for ureter identification. The company's flagship product, the StimSite, is an intuitive handheld device that aids surgeons in quickly and accurately locating ureters during pelvic surgeries. This device features a simple design with a single button, eliminating the need for complex pre- and post-operative procedures. Founded in 2016, Allotrope Medical aims to improve surgical outcomes by providing tools that streamline the identification and localization of ureters, thus facilitating safer and more efficient operations.

VenoStent

Pre Seed Round in 2019
VenoStent, Inc. is a biomaterials and bioengineering company based in Nashville, Tennessee, with an additional office in Houston, Texas. Established in 2017, the company specializes in developing bioresorbable smart polymers aimed at enhancing vascular surgery outcomes. Its primary product, SelfWrap, is a perivascular wrap designed to minimize complications at the junctions of veins and arteries, particularly for dialysis patients. SelfWrap functions as an external stent that promotes outward vein growth and provides mechanical support, thereby reducing the risk of vein collapse. By focusing on innovative solutions in vascular care, VenoStent aims to improve patient outcomes and transform surgical practices.

Ictero Medical

Convertible Note in 2019
Ictero Medical is a medical devices company focused on developing innovative solutions for patients with gallstone disease. The company has created a minimally invasive gallbladder ablation tool that allows for the treatment of high-risk patients without the need for surgical removal of the gallbladder. This device can be utilized in interventional radiology suites and requires only minimal local anesthesia, thereby reducing the associated risks of traditional surgery. By offering a definitive treatment option, Ictero Medical aims to improve patient outcomes while minimizing complications related to gallbladder surgery.

Ikonopedia

Series C in 2019
Ikonopedia, LLC specializes in creating a cloud-based breast study interpretation and reporting system tailored for radiologists. The company offers a Mammography Reporting System that includes screening and diagnostic modalities, generating structured reports compliant with the Mammography Quality Standards Act. Additionally, it provides SonoPro, a web application designed to assist radiologists in interpreting diagnostic breast ultrasound exams. Ikonopedia's solutions enhance workflow efficiency and are utilized in telemammography and satellite clinics. The system features automated patient tracking, ensuring compliance with the ACR BI-RADS® Atlas 5th Edition and monitoring patients through all stages of the exam process. By providing clear and consistent clinical reports, Ikonopedia aims to improve patient safety and streamline operations for radiologists and their staff. Founded in 2012 and headquartered in Dallas, Texas, Ikonopedia addresses critical needs in breast radiology, ultimately contributing to better health outcomes for women.

MacroFab

Series A in 2019
MacroFab is a marketplace for electronics manufacturing from prototype to high scale production. Their platform is re-shaping the $480B contract manufacturing market by transforming the experience from a manual, time-intensive, and error-prone process performed by large teams of people, into a real-time, streamlined, and connected software-driven experience while providing access to unlimited factory capacity in North America. The platform also uploads a PCB board design, gets an instant quote and the board is printed in the company's factory, enabling startups, manufacturers, and enterprises to design, customize and automate the PCB manufacturing process and save time, effort and money. Macrofab was founded in 2013 and is headquartered in Houston, Texas, United States.

TeVido BioDevices

Venture Round in 2019
TeVido BioDevices, Inc. is a biotechnology start-up based in Austin, Texas, focused on developing tissue-engineered products for reconstructive surgery. Established in 2016, the company leverages 3D bio-printing technology and patients' living cells to create custom grafts tailored to individual needs. TeVido's innovative approach aims to enhance options for breast cancer survivors and others experiencing disfigurement, ultimately improving self-esteem and quality of life. In addition to its primary focus on breast reconstruction, TeVido's technology is applicable to a broad range of needs in wound healing and cosmetic surgery, addressing various unmet demands in these fields. The company's advancements in cellular therapy and manufacturing techniques enable the restoration of lost skin color, offering significant improvements in surgical outcomes.

ClearCam

Seed Round in 2018
ClearCam Inc. is a medical technology company based in Austin, Texas, founded in 2018. The company specializes in manufacturing a laparoscopic lens cleaner device known as ClearCam Kelling, which is designed to enhance the visual field for surgeons during laparoscopic procedures. This innovative device allows for intra-operative lens cleaning without the need to remove the laparoscope from the body cavity, thereby streamlining surgical processes and improving safety. By eliminating the requirement for additional supplies, ClearCam's technology contributes to reduced procedure time, benefiting patients, surgeons, and surgical staff alike.

TeVido BioDevices

Seed Round in 2018
TeVido BioDevices, Inc. is a biotechnology start-up based in Austin, Texas, focused on developing tissue-engineered products for reconstructive surgery. Established in 2016, the company leverages 3D bio-printing technology and patients' living cells to create custom grafts tailored to individual needs. TeVido's innovative approach aims to enhance options for breast cancer survivors and others experiencing disfigurement, ultimately improving self-esteem and quality of life. In addition to its primary focus on breast reconstruction, TeVido's technology is applicable to a broad range of needs in wound healing and cosmetic surgery, addressing various unmet demands in these fields. The company's advancements in cellular therapy and manufacturing techniques enable the restoration of lost skin color, offering significant improvements in surgical outcomes.

Your Fare

Seed Round in 2018
Your Fare is an online ordering management platform for restaurants that allows its users to track sales on one dashboard. It also allows restaurateurs to replace their online ordering tablets. It helps manage all 3rd party delivery services in a way that works best for its user. It was built for restaurant operators, by restaurant operators. It was founded in 2015 and is headquartered in Austin, Texas.

VenoStent

Pre Seed Round in 2018
VenoStent, Inc. is a biomaterials and bioengineering company based in Nashville, Tennessee, with an additional office in Houston, Texas. Established in 2017, the company specializes in developing bioresorbable smart polymers aimed at enhancing vascular surgery outcomes. Its primary product, SelfWrap, is a perivascular wrap designed to minimize complications at the junctions of veins and arteries, particularly for dialysis patients. SelfWrap functions as an external stent that promotes outward vein growth and provides mechanical support, thereby reducing the risk of vein collapse. By focusing on innovative solutions in vascular care, VenoStent aims to improve patient outcomes and transform surgical practices.

Riders Share

Seed Round in 2018
Riders Share is a peer-to-peer marketplace that specializes in street-legal motorcycle rentals. The platform allows motorcycle owners to list their bikes, enabling riders to choose from a wide variety of options, from low-capacity models to high-end custom motorcycles. This service simplifies the rental process, eliminating the hassles associated with traditional rental companies. Riders Share operates in major cities across the United States, including Los Angeles, New York, and Miami, offering a diverse inventory of over 2,000 motorcycles, making it the largest source for motorcycle rentals in the country. The company also prioritizes safety by screening potential renters and providing insurance, which fosters a trustworthy environment for both renters and bike owners.

myLABBox

Seed Round in 2018
myLAB Box is a pioneer in providing at-home testing solutions that empower individuals to manage their sexual health and overall well-being. The company offers a range of testing kits, including those for STDs, fertility, nutrition, diabetes, vitamin deficiencies, and toxicity, allowing users to conduct tests in the privacy of their homes. With its innovative service, the Safe Box, myLAB Box aims to transform the conversation and approach to sexual health by making testing accessible, affordable, and convenient. This approach not only facilitates a greater understanding of personal health but also promotes proactive health management.

Glycos Biotechnologies

Seed Round in 2018
Glycos Biotechnologies, Inc. is a Houston-based company specializing in food science and biotechnology. Founded in 2007, it focuses on developing personalized nutritional foods aimed at addressing dietary deficiencies associated with various health conditions. Its product offerings include Monomega, a pre-digested form of essential omega-3 fatty acids for cell growth; Monomega-V, which enhances the delivery of essential fatty acids along with vitamins; and Peptide Plus, a plant-based protein hydrolysate tailored for individual gut functions. In addition to its nutritional products, Glycos Biotechnologies collaborates with partners in the fuels and chemicals sectors to facilitate the production of high-value products from non-food feedstocks, helping to enhance profitability and reduce carbon footprints. The company works with ethanol and biodiesel businesses, as well as biorefinery operators, to provide integrated solutions for alternative chemicals and fuels production.

PolyPort

Seed Round in 2018
PolyPort Inc. specializes in developing encryption software for managing and securing three-dimensional (3D) and two-dimensional (2D) digital assets. Founded in 2016 and based in Chamblee, Georgia, the company provides a platform that enables designers, engineers, and artists to create and collaborate on various projects while ensuring the protection and control of their intellectual property. PolyPort's software allows users to seamlessly integrate their existing tools and workflows without the need for additional hardware or plugins, facilitating immediate access to design capabilities. The platform supports tracking and management of assets, enabling content owners to share their work with external brands and collaborators while maintaining control over permissions and usage.

SIERA.AI

Pre Seed Round in 2018
SIERA.AI specializes in providing software-as-a-service (SaaS) solutions for industrial vehicle inspections and offers Internet of Things (IoT) driver assistance technology aimed at enhancing safety and productivity. The company delivers a data-driven dashboard that allows enterprises to monitor individual drivers, thereby managing risk and improving operational efficiency. SIERA.AI's after-market middleware technology is compatible with various brands and models, enabling seamless integration with leading global manufacturers. Founded in 2017 and based in Austin, Texas, SIERA.AI is committed to advancing the capabilities of automated material handling through innovative technology.

Materna Medical

Series A in 2016
Materna Medical, Inc. is a medical device company based in Mountain View, California, specializing in products aimed at enhancing women's pelvic health and reducing childbirth-related injuries. Established in 2010, the company launched Milli in 2018, the first expanding vaginal dilator designed to alleviate pelvic pain, a condition affecting over 20 million women. Materna Medical is also conducting a clinical trial for Materna Prep, a device intended to be used during the first stage of labor to expedite delivery and minimize internal damage to the pelvic region. The innovative features of Materna's devices not only provide significant health benefits to patients but also aim to save physicians' time, shorten delivery durations, and reduce overall healthcare costs by decreasing the incidence of pelvic injuries.

Infrastructure Networks

Venture Round in 2016
Infrastructure Networks provides services for the acquisition and delivery of natural energy resources required to power a modern economy. It eliminates the frustrations associated with managing and scaling remote communications by providing end-to-end customer connectivity solutions. By leveraging the global scale and adoption of a leading standards-compliant technology, recognized technology leaders, along with 24/7 monitoring and boots-on-ground service, INET delivers “Wireless Infrastructure-as-a-Service” (W-Iaas) over the industry’s first end-to-end, private, LTE network. The company was founded in 2011 and is based in Houston, Texas.

DNAtrix

Convertible Note in 2016
DNAtrix, Inc. is a clinical stage biotechnology company based in Houston, Texas, specializing in virus-driven immunotherapies for cancer treatment. The company develops modified viruses designed to selectively target and kill cancer cells, with its lead product, DNX-2401, focused on glioblastoma, an aggressive and currently incurable brain tumor. This oncolytic immunotherapy has shown promising early results, having been administered to over 35 patients. In addition to DNX-2401, DNAtrix is advancing other therapies, including DNX-2440 and DNX-2450 for solid tumors, and MYX-135 for hematological malignancies. The company aims to expand its platform technology to address a broader range of cancers, including brain metastases, ovarian, and pancreatic cancer. DNAtrix has formed a strategic partnership with Valo Therapeutics to enhance its research and development efforts.

Onit

Venture Round in 2016
Onit, Inc. specializes in developing legal project management and workflow automation software designed to enhance productivity and streamline operations across various business departments. The company's offerings include Enterprise Legal Management, Matter Management, Legal Spend Management, Contract Lifecycle Management, and Legal Holds, which collectively facilitate the efficient handling of legal matters and spending. Additionally, Onit provides a self-service portal for Legal Service Requests and tools like Apptitude for workflow automation and Precedent, an artificial intelligence platform. By allowing users to create custom applications without reliance on IT support, Onit simplifies business processes that are typically manual and cumbersome. Founded in 2011 and headquartered in Houston, Texas, with additional offices in Austin, Auckland, and Pune, Onit serves a diverse range of industries, including technology, insurance, healthcare, and finance, helping clients to automate processes, reduce costs, and maximize productivity.

Quad Technologies

Convertible Note in 2016
Quad Technologies is disrupting cell separation and cell therapy workflows by providing researchers with a simple, cell-friendly capture and release technology for cell isolation. Their new MagCloudz™ Streptavidin Cell Separation kit, featuring novel QuickGel™ technology platform, enables straightforward, scalable and fast cell separation with unique magnetic particle dissociation, resulting in complete label free cells. For applications such as T Cell purification, stem cell isolation, circulating tumor cell (CTC) separation and immunotherapy, this unique solution offers drastically improved cell viability, purity and recovery while maintaining a native cellular phenotype.

Dynamo Micropower

Angel Round in 2016
Dynamo Micropower Corporation specializes in developing fuel-flexible gas turbines designed for small distributed generation applications in the oil and gas industry. The company's notable products include PowerCore, which provides continuous power for oilfield operations, and Infernocore, a flameless turboheater. Dynamo's innovative turbine-based solutions offer grid-like power quality while significantly reducing energy costs, with the capability to operate on local unrefined gas, achieving savings of up to 80%. The company also delivers custom power solutions tailored to the specific needs of its clients, facilitating plug-and-play installation on flare gas. Dynamo has established a network of distributors and service partners to support its offerings. Founded in 2011 and based in Somerville, Massachusetts, Dynamo has successfully deployed multiple turbines for prominent customers in the industry.

Adient Medical

Series C in 2016
Adient’s mission is the development of absorbable medical devices with the premise that implants should be safe and efficacious during their useful lifetime, and then simply vanish without intervention, alleviating costly removal procedures and downstream complications.

Autonomous Marine Systems

Seed Round in 2016
Autonomous Marine Systems Inc. is a marine data services company based in Somerville, Massachusetts, founded in 2009. The company specializes in providing customized hydrographic surveys and operates low-cost, self-powered ocean surface drones that form an intelligent sensor network for data collection. Its robotic sailboats, which harness wind and solar energy, are designed for autonomous operation on long-duration missions across vast geographic areas. This technology allows clients in sectors such as defense, energy, shipping, fishing, and research to efficiently gather marine data while minimizing risks to human life and reducing the operational costs associated with traditional vessels in challenging marine environments.

Autonomous Marine Systems

Seed Round in 2016
Autonomous Marine Systems Inc. is a marine data services company based in Somerville, Massachusetts, founded in 2009. The company specializes in providing customized hydrographic surveys and operates low-cost, self-powered ocean surface drones that form an intelligent sensor network for data collection. Its robotic sailboats, which harness wind and solar energy, are designed for autonomous operation on long-duration missions across vast geographic areas. This technology allows clients in sectors such as defense, energy, shipping, fishing, and research to efficiently gather marine data while minimizing risks to human life and reducing the operational costs associated with traditional vessels in challenging marine environments.

myLABBox

Angel Round in 2015
myLAB Box is a pioneer in providing at-home testing solutions that empower individuals to manage their sexual health and overall well-being. The company offers a range of testing kits, including those for STDs, fertility, nutrition, diabetes, vitamin deficiencies, and toxicity, allowing users to conduct tests in the privacy of their homes. With its innovative service, the Safe Box, myLAB Box aims to transform the conversation and approach to sexual health by making testing accessible, affordable, and convenient. This approach not only facilitates a greater understanding of personal health but also promotes proactive health management.

Quad Technologies

Series A in 2015
Quad Technologies is disrupting cell separation and cell therapy workflows by providing researchers with a simple, cell-friendly capture and release technology for cell isolation. Their new MagCloudz™ Streptavidin Cell Separation kit, featuring novel QuickGel™ technology platform, enables straightforward, scalable and fast cell separation with unique magnetic particle dissociation, resulting in complete label free cells. For applications such as T Cell purification, stem cell isolation, circulating tumor cell (CTC) separation and immunotherapy, this unique solution offers drastically improved cell viability, purity and recovery while maintaining a native cellular phenotype.

Adient Medical

Seed Round in 2015
Adient’s mission is the development of absorbable medical devices with the premise that implants should be safe and efficacious during their useful lifetime, and then simply vanish without intervention, alleviating costly removal procedures and downstream complications.

HUVRData

Seed Round in 2015
HUVRData, LLC specializes in developing enterprise asset management software designed to enhance return on investment for asset owners through digital maintenance and inspection workflows. The company's offerings include InspectFlow, a platform for digitizing inspection checklists; ImageFlow, which processes inspection images and allows for tagging and annotating damage; and Anytime / Anywhere Forms, enabling field inspectors to document issues in real-time. Additionally, HUVRData provides a central control panel for asset management, a reporting tool for various formats, and an analytics engine that delivers actionable insights and trend analysis. The firm serves a diverse clientele, including asset owners and service providers in the renewables, oil and gas, maritime, and utility sectors, catering to Fortune 500 companies across multiple industries. Founded in 2014 and based in Austin, Texas, HUVRData focuses on facilitating digital transformation and breaking down data silos within enterprise asset management.

Set.fm

Convertible Note in 2015
Set.fm, Inc. is an online platform based in Austin, Texas, that enables live concert performers to capture and sell recordings of their performances immediately after the show. Founded in 2012 and formerly known as DejaSet, Inc., Set.fm provides a user-friendly mobile application that allows musicians to easily record high-quality audio using existing equipment. This innovative service allows artists to tap into new revenue streams by promoting and selling their live recordings directly to fans, who can purchase copies of performances before leaving the venue. As a subsidiary of VNUE, Inc., Set.fm is committed to enhancing the live music experience for both performers and audiences.

Materna Medical

Seed Round in 2014
Materna Medical, Inc. is a medical device company based in Mountain View, California, specializing in products aimed at enhancing women's pelvic health and reducing childbirth-related injuries. Established in 2010, the company launched Milli in 2018, the first expanding vaginal dilator designed to alleviate pelvic pain, a condition affecting over 20 million women. Materna Medical is also conducting a clinical trial for Materna Prep, a device intended to be used during the first stage of labor to expedite delivery and minimize internal damage to the pelvic region. The innovative features of Materna's devices not only provide significant health benefits to patients but also aim to save physicians' time, shorten delivery durations, and reduce overall healthcare costs by decreasing the incidence of pelvic injuries.

DNAtrix

Series B in 2014
DNAtrix, Inc. is a clinical stage biotechnology company based in Houston, Texas, specializing in virus-driven immunotherapies for cancer treatment. The company develops modified viruses designed to selectively target and kill cancer cells, with its lead product, DNX-2401, focused on glioblastoma, an aggressive and currently incurable brain tumor. This oncolytic immunotherapy has shown promising early results, having been administered to over 35 patients. In addition to DNX-2401, DNAtrix is advancing other therapies, including DNX-2440 and DNX-2450 for solid tumors, and MYX-135 for hematological malignancies. The company aims to expand its platform technology to address a broader range of cancers, including brain metastases, ovarian, and pancreatic cancer. DNAtrix has formed a strategic partnership with Valo Therapeutics to enhance its research and development efforts.

Wonder Technologies

Seed Round in 2014
Wonder Technologies, Inc. operates a marketplace for consumers to discover and purchase e-gift cards from a variety of national retailers and local specialty stores across the United States. Based in Laguna Beach, California, the company provides a platform that allows users to redeem gift cards at numerous merchants, including coffee shops, restaurants, and spas, by using their credit cards. Through its iOS application, customers can conveniently buy e-gift cards. Additionally, Wonder Technologies offers a card-linked solution designed to streamline the processes of issuing, sending, redeeming, and tracking digital promotions. This innovative approach helps merchants to quickly implement and assess the effectiveness of their marketing initiatives while enhancing customer engagement.

Siotex

Seed Round in 2014
SioTeX Corporation, established in 2014 and based in San Marcos, Texas, specializes in the manufacture of specialty chemicals and performance materials. The company has developed Eco-Sil, a sustainable and efficient drop-in replacement for fumed silica, utilizing rice hulls—a widely available biowaste—as its primary raw material. This innovative approach not only simplifies the production process significantly but also reduces energy consumption and minimizes the use of toxic reactants compared to traditional methods. SioTeX's technology addresses the environmental issue of rice hull waste, which is often discarded in landfills or burned in the fields, and has gained recognition for its contributions to waste reduction, including an award from the Environmental Protection Agency.

Cerebrotech Medical Systems

Venture Round in 2014
Cerebrotech Medical Systems, Inc. is focused on developing non-invasive monitoring technology for patients recovering from stroke or traumatic brain injury. The company's primary product, the Cerebrotech monitor, is designed to detect early signs of cerebral fluid accumulation, such as edema or bleeding, which can arise from various neurological conditions. By providing continuous monitoring, the device alerts healthcare providers to increases in brain fluids before intracranial pressure spikes, thus enabling timely interventions to prevent potential brain damage. Founded in 2010 and based in Pleasanton, California, Cerebrotech aims to enhance patient outcomes by reducing treatment delays during neurological assessments.

Deep Imaging Technologies

Venture Round in 2014
Deep Imaging Technologies, Inc. is a subsurface imaging company based in Tomball, Texas, that specializes in developing advanced data collection equipment and software for the oil and gas industry. Founded in 2008, the company focuses on creating surface imaging systems that utilize electromagnetic fields generated at very low frequencies to effectively visualize geological features. Its portfolio includes transmitters, receivers, and software designed for processing and imaging, enabling clients to better understand subsurface conditions.

Autonomous Marine Systems

Seed Round in 2014
Autonomous Marine Systems Inc. is a marine data services company based in Somerville, Massachusetts, founded in 2009. The company specializes in providing customized hydrographic surveys and operates low-cost, self-powered ocean surface drones that form an intelligent sensor network for data collection. Its robotic sailboats, which harness wind and solar energy, are designed for autonomous operation on long-duration missions across vast geographic areas. This technology allows clients in sectors such as defense, energy, shipping, fishing, and research to efficiently gather marine data while minimizing risks to human life and reducing the operational costs associated with traditional vessels in challenging marine environments.

TNG Pharmaceuticals

Series A in 2014
TNG Pharmaceuticals, based in Louisville, Kentucky, specializes in the research and development of a veterinary vaccine known as FlyVax, aimed at reducing the horn fly population that affects cattle. Utilizing recombinant protein technology, FlyVax inhibits the horn fly's ability to feed by counteracting its anti-clotting agent, Thrombostasin, thereby provoking an immune response that promotes blood clotting at the site of the wound. Founded in 2011, TNG Pharmaceuticals originated from the University of Louisville's Entrepreneurship MBA program and has gained recognition by winning multiple global business plan competitions.

Quarri

Series C in 2013
Quarri Technologies, Inc. specializes in developing web security software aimed at safeguarding endpoints and sensitive data for organizations. Its key offerings include Perimeter Shield, which protects web applications from malware and network attacks; Data Safe, which controls and secures browser-delivered information; and Armored Browser, designed to defend Windows systems against web-borne malware. Additionally, Quarri provides MyPOQ, a secure web browser for various devices, along with solutions for online banking security, PCI compliance, cloud application security, and intellectual property protection. The company serves clients across North America, Europe, and the Middle East, enabling enterprises to implement security measures for web applications and prevent data leakage regardless of the user's location. Quarri Technologies, originally founded as Quaresso Software Technologies in 2007, is based in Austin, Texas, but filed for liquidation in December 2017.

TNG Pharmaceuticals

Seed Round in 2013
TNG Pharmaceuticals, based in Louisville, Kentucky, specializes in the research and development of a veterinary vaccine known as FlyVax, aimed at reducing the horn fly population that affects cattle. Utilizing recombinant protein technology, FlyVax inhibits the horn fly's ability to feed by counteracting its anti-clotting agent, Thrombostasin, thereby provoking an immune response that promotes blood clotting at the site of the wound. Founded in 2011, TNG Pharmaceuticals originated from the University of Louisville's Entrepreneurship MBA program and has gained recognition by winning multiple global business plan competitions.

Cinegif

Seed Round in 2013
Cinegif is an Austin, Texas-based software development company whose patented video conversion software helps marketers communicate and tell a story, without the file size, complexity, and cost of traditional video. Branding professionals, email marketing firms, and web hosting companies use Cinegifs to improve customer engagement on web pages, e-mail, social media, text messages, and digital signage.

AdventureLink

Seed Round in 2012
AdventureLink Travel, Inc. operates an online booking system that facilitates research and reservations for adventure travel globally. Founded in 2006 and based in Altadena, California, the platform enables travelers to discover and book a variety of activities, including hiking, scuba diving, and culinary experiences across diverse regions, such as Africa, Asia, and North America. By aggregating top tour operators, AdventureLink simplifies the booking process for consumers and travel agents alike, allowing for easy comparison of trips. The platform operates on a software as a service (SaaS) model, enhancing scalability and margins as more partners join. With an estimated $130 billion industry potential, AdventureLink positions itself as a key player in the growing market for experiential travel, catering to the preferences of millennials and aging baby boomers. Its proprietary platform is favored by large travel retailers, offering a comprehensive solution that is challenging to replicate.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.